What age groups were included in Polivy (polatuzumab vedotin) clinical trials?
Polivy’s key clinical studies enrolled a range of adult ages, but the exact age-group breakdown (for example, how many participants were 18–64 vs. 65+) depends on the specific trial and dataset.
From the information available to me here, I can’t specify the exact age-group participation numbers for Polivy’s trials without the specific trial name (for example, the randomized study vs. the single-arm study) or the source table that lists age groups.
Which Polivy trial are you looking at?
To pinpoint the age groups, you’ll need to tell me which study you mean. Common Polivy trial names/programs include the major solid-tumor lymphoma studies and the randomized combination study in relapsed/refractory DLBCL.
If you share either:
- the trial identifier (e.g., NCT number), or
- the publication label you’re reading,
I can extract the participating age ranges (and any reported age categories) from that specific trial.
What I need from you to answer precisely
Reply with one of the following so I can give the age-group participation exactly as reported:
1) The trial name or NCT number, or
2) A link or screenshot of the table/section that lists “Age group,” or
3) Whether you mean DLBCL trials specifically, and which combination arm (e.g., with bendamustine/rituximab vs other regimens).
Source
No sources were provided with your question, and I don’t have the trial age-group table to cite.